TapewireFind a company

person · Reporting owner

Larsen Jill

Disclosed activity across 3 companies

Tapewire entity
78735
SEC CIK
0001738092

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Definitive Healthcare Corp.DH · Entity 1538DirectorJune 05, 2025June 09, 2025

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Definitive Healthcare Corp.

Report date June 05, 2025 · Filed June 09, 2025

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Class A Common StockSEC Table I · non-derivativeDirect114,751 Reported balance After 2025-06-05 transaction · row 1
1 source row

Row 1 · 2025-06-05 · Grant · Acquired 55,911 · Balance 114,751

F1: Represents restricted stock units ("RSUs"), each representing a contingent right to receive one share of the Issuer's Class A Common Stock, par value $0.001, vesting on the earlier of June 5, 2026 or the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date.

Filing footnotes · ownership attribution and instrument terms

F1: Represents restricted stock units ("RSUs"), each representing a contingent right to receive one share of the Issuer's Class A Common Stock, par value $0.001, vesting on the earlier of June 5, 2026 or the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date.

Past disclosures · reporting ended (2)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Medidata Solutions, Inc.

Report date October 28, 2019 · Filed October 28, 2019

Section 16 reporting ended · disclosed 2019-10-28. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect0 Reported balance After 2019-10-28 transaction · row 1
1 source row

Row 1 · 2019-10-28 · Disposition to issuer · Disposed 45,555 · Balance 0

F1: On October 28, 2019, pursuant to the Agreement and Plan of Merger, dated as of June 11, 2019, by and among Dassault Systemes SE ("DS"), Dassault Systemes Americas Corp., a Delaware corporation ("Parent"), 3DS Acquisition 6 Corp., a Delaware corporation and a wholly-owned subsidiary of Parent ("Merger Sub"), and Medidata Solutions, Inc., a Delaware corporation (the "Issuer"), Merger Sub merged with and into the Issuer, with the Issuer surviving as a wholly-owned subsidiary of Parent and an indirect wholly-owned subsidiary of DS (the "Merger"). Pursuant to the separation agreement by and between the reporting person and the Issuer, dated October 25, 2019, each of the reporting person's shares of restricted stock will be deemed a Non-Employee RSA under the terms of the Merger Agreement.

F2: Disposed of pursuant to the Merger Agreement and by virtue of the Merger, in which each share of Medidata common stock, par value $0.01 per share ("Issuer Common Stock"), issued and outstanding immediately prior to the completion of the Merger (other than restricted share awards held by continuing employees) was converted into the right to receive $92.25 in cash and without interest (the "Merger Consideration"). Such number of shares includes shares issued to the reporting person upon accelerated vesting of the reporting person's RSAs and Issuer PBRSUs (referred to below) immediately prior to the effective time of the Merger.

F3: Included are 174 shares which were purchased pursuant to the terms of the Medidata Solutions, Inc. Employee Stock Purchase Plan on June 30, 2019.

Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $72.51 · Expires 2028-04-23Direct0 Reported balance After 2019-10-28 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2019-10-28 · Disposition to issuer · Disposed 17,200 · Balance 0

F4: Pursuant to the Merger Agreement and by virtue of the Merger, each option to purchase Issuer Common Stock will be cancelled and converted into the right to receive an amount in cash (without interest and subject to deduction for any required withholding tax) equal to the product of (1) the total number of shares of Issuer Common Stock then covered by such option multiplied by (2) the excess, if any, of $92.25 per share over the exercise price per share under such option.

F5: The options vested as to 25% of the shares on April 23, 2019 and 1/36th of the remaining options will become exercisable each month thereafter for the next 36 months.

Restricted Stock Units (Performance-Related)SEC Table II · derivative / convertible security · Conversion / exercise price $0.00Direct0 Reported balance After 2019-10-28 transaction · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · 2019-10-28 · Disposition to issuer · Disposed 10,343 · Balance 0

F6: Pursuant to the separation agreement by and between the reporting person and the Issuer, dated October 25, 2019, each of the reporting person's performance-based restricted stock units will be deemed a Non-Employee PSU under the terms of the Merger Agreement and will be cancelled and converted into the right to receive an amount in cash equal to the product of (1) the total number of shares of Issuer Common Stock then covered by such PSU based on the attainment of the applicable performance metrics as determined by the issuer's Compensation committee multiplied by (2) $92.25 per share.

F7: Award of PBRSUs granted under the 2017 LTIP on April 23, 2018. The number of PBRSUs represented a target amount. Each PBRSU represented a contingent right to receive 0-200% of that target number of shares of the issuer's common stock, (i) 50% based on the issuer's TSR as compared to the TSR of companies in the Russell 2000 Index for the three years ending December 31, 2020, and (ii) 50% based on the Company's GAAP Net Income attainment for the three years ending December 31, 2020. The shares would have vested immediately upon being earned.

Restricted Stock Units (Performance Related)SEC Table II · derivative / convertible security · Conversion / exercise price $0.00Direct0 Reported balance After 2019-10-28 transaction · row 4 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 4 · 2019-10-28 · Disposition to issuer · Disposed 19,954 · Balance 0

F6: Pursuant to the separation agreement by and between the reporting person and the Issuer, dated October 25, 2019, each of the reporting person's performance-based restricted stock units will be deemed a Non-Employee PSU under the terms of the Merger Agreement and will be cancelled and converted into the right to receive an amount in cash equal to the product of (1) the total number of shares of Issuer Common Stock then covered by such PSU based on the attainment of the applicable performance metrics as determined by the issuer's Compensation committee multiplied by (2) $92.25 per share.

F8: Award of PBRSUs granted under the 2017 LTIP on February 12, 2019. The number of PBRSUs represented a target amount. Each PBRSU represented a contingent right to receive 0-225% of that target number of shares of the issuer's common stock, (i) 50% based on the issuer's TSR as compared to the TSR of companies in the Russell 2000 Index for the three years ending December 31, 2021, and (ii) 50% based on the Company's revenue attainment for the three years ending December 31, 2021. The shares would have vested immediately upon being earned.

Filing footnotes · ownership attribution and instrument terms

F1: On October 28, 2019, pursuant to the Agreement and Plan of Merger, dated as of June 11, 2019, by and among Dassault Systemes SE ("DS"), Dassault Systemes Americas Corp., a Delaware corporation ("Parent"), 3DS Acquisition 6 Corp., a Delaware corporation and a wholly-owned subsidiary of Parent ("Merger Sub"), and Medidata Solutions, Inc., a Delaware corporation (the "Issuer"), Merger Sub merged with and into the Issuer, with the Issuer surviving as a wholly-owned subsidiary of Parent and an indirect wholly-owned subsidiary of DS (the "Merger"). Pursuant to the separation agreement by and between the reporting person and the Issuer, dated October 25, 2019, each of the reporting person's shares of restricted stock will be deemed a Non-Employee RSA under the terms of the Merger Agreement.

F2: Disposed of pursuant to the Merger Agreement and by virtue of the Merger, in which each share of Medidata common stock, par value $0.01 per share ("Issuer Common Stock"), issued and outstanding immediately prior to the completion of the Merger (other than restricted share awards held by continuing employees) was converted into the right to receive $92.25 in cash and without interest (the "Merger Consideration"). Such number of shares includes shares issued to the reporting person upon accelerated vesting of the reporting person's RSAs and Issuer PBRSUs (referred to below) immediately prior to the effective time of the Merger.

F3: Included are 174 shares which were purchased pursuant to the terms of the Medidata Solutions, Inc. Employee Stock Purchase Plan on June 30, 2019.

F4: Pursuant to the Merger Agreement and by virtue of the Merger, each option to purchase Issuer Common Stock will be cancelled and converted into the right to receive an amount in cash (without interest and subject to deduction for any required withholding tax) equal to the product of (1) the total number of shares of Issuer Common Stock then covered by such option multiplied by (2) the excess, if any, of $92.25 per share over the exercise price per share under such option.

F5: The options vested as to 25% of the shares on April 23, 2019 and 1/36th of the remaining options will become exercisable each month thereafter for the next 36 months.

F6: Pursuant to the separation agreement by and between the reporting person and the Issuer, dated October 25, 2019, each of the reporting person's performance-based restricted stock units will be deemed a Non-Employee PSU under the terms of the Merger Agreement and will be cancelled and converted into the right to receive an amount in cash equal to the product of (1) the total number of shares of Issuer Common Stock then covered by such PSU based on the attainment of the applicable performance metrics as determined by the issuer's Compensation committee multiplied by (2) $92.25 per share.

F7: Award of PBRSUs granted under the 2017 LTIP on April 23, 2018. The number of PBRSUs represented a target amount. Each PBRSU represented a contingent right to receive 0-200% of that target number of shares of the issuer's common stock, (i) 50% based on the issuer's TSR as compared to the TSR of companies in the Russell 2000 Index for the three years ending December 31, 2020, and (ii) 50% based on the Company's GAAP Net Income attainment for the three years ending December 31, 2020. The shares would have vested immediately upon being earned.

F8: Award of PBRSUs granted under the 2017 LTIP on February 12, 2019. The number of PBRSUs represented a target amount. Each PBRSU represented a contingent right to receive 0-225% of that target number of shares of the issuer's common stock, (i) 50% based on the issuer's TSR as compared to the TSR of companies in the Russell 2000 Index for the three years ending December 31, 2021, and (ii) 50% based on the Company's revenue attainment for the three years ending December 31, 2021. The shares would have vested immediately upon being earned.

Sterling Check Corp.

Report date October 31, 2024 · Filed November 04, 2024

Section 16 reporting ended · disclosed 2024-11-04. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect0 Reported balance After 2024-10-31 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2024-10-31 · Disposition to issuer · Disposed 34,415 · Balance 0

F1: The shares of Company common stock ("Company Common Stock") were disposed of pursuant to the Agreement and Plan of Merger, dated as of February 28, 2024 (the "Merger Agreement"), by and among Sterling Check Corp., a Delaware corporation (the "Company"), First Advantage Corporation, a Delaware corporation ("Parent"), and Starter Merger Sub, Inc., a Delaware corporation and an indirect wholly-owned subsidiary of Parent, whereby at the effective time of the merger contemplated therein (the "Effective Time"), [Footnote continued below]

F2: [Footnote continued from above] each share of Company Common Stock issued and outstanding immediately prior to the Effective Time was converted into the right to receive, at the election of the holder of such share of Company Common Stock, and subject to proration in accordance with the Merger Agreement: (i) $16.73 per share in cash, without interest (the "Cash Consideration") or (ii) 0.979 shares of common stock, par value $0.001 per share, of Parent, together with cash in lieu of fractional shares, if any, at the rate per share of common stock of Parent of the last reported sale price of common stock of Parent on NASDAQ (as reported in The Wall Street Journal or, if not reported therein, in another authoritative source mutually selected by Parent and the Company) on the last complete trading day prior to the date of the Effective Time (the "Stock Consideration").

Common StockSEC Table I · non-derivativeDirect0 Reported balance After 2024-10-31 transaction · row 3 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 3 · 2024-10-31 · Disposition to issuer · Disposed 12,756 · Balance 0

F3: This number reflects the number of shares of Company Common Stock subject to outstanding restricted stock awards.

F4: Pursuant to the Merger Agreement, as of the Effective Time, each restricted share of Company Common Stock (each, a "Company Restricted Share") was converted into the right to receive, at the election of the holder of such Company Restricted Share, and subject to proration in accordance with the Merger Agreement: (i) $16.73 per share in restricted cash (the "Restricted Cash Consideration") or (ii) 0.979 shares of Stock Consideration, in the form of restricted stock of Parent (the "Restricted Stock Consideration"), in either case, subject to substantially the same terms and conditions as were applicable to such Company Restricted Shares.

Common StockSEC Table I · non-derivativeIndirectOwned through DigitalHR, LLC.0 Reported balance After 2024-10-31 transaction · row 2 Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source row

Row 2 · 2024-10-31 · Disposition to issuer · Disposed 30,982 · Balance 0

F1: The shares of Company common stock ("Company Common Stock") were disposed of pursuant to the Agreement and Plan of Merger, dated as of February 28, 2024 (the "Merger Agreement"), by and among Sterling Check Corp., a Delaware corporation (the "Company"), First Advantage Corporation, a Delaware corporation ("Parent"), and Starter Merger Sub, Inc., a Delaware corporation and an indirect wholly-owned subsidiary of Parent, whereby at the effective time of the merger contemplated therein (the "Effective Time"), [Footnote continued below]

F2: [Footnote continued from above] each share of Company Common Stock issued and outstanding immediately prior to the Effective Time was converted into the right to receive, at the election of the holder of such share of Company Common Stock, and subject to proration in accordance with the Merger Agreement: (i) $16.73 per share in cash, without interest (the "Cash Consideration") or (ii) 0.979 shares of common stock, par value $0.001 per share, of Parent, together with cash in lieu of fractional shares, if any, at the rate per share of common stock of Parent of the last reported sale price of common stock of Parent on NASDAQ (as reported in The Wall Street Journal or, if not reported therein, in another authoritative source mutually selected by Parent and the Company) on the last complete trading day prior to the date of the Effective Time (the "Stock Consideration").

Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $23.00Direct0 Reported balance After 2024-10-31 transaction · row 4 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 4 · 2024-10-31 · Disposition to issuer · Disposed 24,424 · Balance 0

F8: Pursuant to the Merger Agreement, as of the Effective Time, each outstanding out-of-the-money Company Stock option (i.e., a stock option that has an exercise price per share that is greater than the per-share cash consideration of $16.73), whether vested or unvested, was canceled for no consideration.

Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.68Direct0 Reported balance After 2024-10-31 transaction · row 5 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 5 · 2024-10-31 · Disposition to issuer · Disposed 73,101 · Balance 0

F5: Pursuant to the Merger Agreement, as of the Effective Time, each outstanding in-the-money Company stock option (i.e., a stock option that has an exercise price per share that is less than the per-share cash consideration of $16.73) (each, an "In-The-Money Company Stock Option"), whether vested or unvested, was canceled, with the holder becoming entitled to receive merger consideration based on each share of Net Option Stock that is associated with such In-The-Money Company Stock Option. The number of shares of "Net Option Stock" subject to an In-The-Money Company Stock Option is the number of shares of Company Common Stock equal to the excess of $16.73 over the per-share exercise price of such In-The-Money Company Stock Option multiplied by the number of shares of Company Common Stock underlying such In-The-Money Company Stock Option divided by $16.73.

F6: Pursuant to the Merger Agreement, as of the Effective Time, each outstanding share of Net Option Stock associated with vested In-The-Money Company Stock Options ("Vested Net Option Stock") was converted into the right to receive, at the election of the holder, and subject to proration in accordance with the Merger Agreement: (i) the Cash Consideration or (ii) the Stock Consideration.

F7: Pursuant to the Merger Agreement, as of the Effective Time, each outstanding share of Net Option Stock associated with unvested In-The-Money Company Stock Options ("Unvested Net Option Stock") was converted into the right to receive, at the election of the holder, and subject to proration in accordance with the Merger Agreement: (i) the Restricted Cash Consideration or (ii) the Restricted Stock Consideration, in either case, subject to substantially the same terms and conditions as were applicable under such In-The-Money Company Stock Options underlying the Unvested Net Option Stock.

Filing footnotes · ownership attribution and instrument terms

F1: The shares of Company common stock ("Company Common Stock") were disposed of pursuant to the Agreement and Plan of Merger, dated as of February 28, 2024 (the "Merger Agreement"), by and among Sterling Check Corp., a Delaware corporation (the "Company"), First Advantage Corporation, a Delaware corporation ("Parent"), and Starter Merger Sub, Inc., a Delaware corporation and an indirect wholly-owned subsidiary of Parent, whereby at the effective time of the merger contemplated therein (the "Effective Time"), [Footnote continued below]

F2: [Footnote continued from above] each share of Company Common Stock issued and outstanding immediately prior to the Effective Time was converted into the right to receive, at the election of the holder of such share of Company Common Stock, and subject to proration in accordance with the Merger Agreement: (i) $16.73 per share in cash, without interest (the "Cash Consideration") or (ii) 0.979 shares of common stock, par value $0.001 per share, of Parent, together with cash in lieu of fractional shares, if any, at the rate per share of common stock of Parent of the last reported sale price of common stock of Parent on NASDAQ (as reported in The Wall Street Journal or, if not reported therein, in another authoritative source mutually selected by Parent and the Company) on the last complete trading day prior to the date of the Effective Time (the "Stock Consideration").

F3: This number reflects the number of shares of Company Common Stock subject to outstanding restricted stock awards.

F4: Pursuant to the Merger Agreement, as of the Effective Time, each restricted share of Company Common Stock (each, a "Company Restricted Share") was converted into the right to receive, at the election of the holder of such Company Restricted Share, and subject to proration in accordance with the Merger Agreement: (i) $16.73 per share in restricted cash (the "Restricted Cash Consideration") or (ii) 0.979 shares of Stock Consideration, in the form of restricted stock of Parent (the "Restricted Stock Consideration"), in either case, subject to substantially the same terms and conditions as were applicable to such Company Restricted Shares.

F5: Pursuant to the Merger Agreement, as of the Effective Time, each outstanding in-the-money Company stock option (i.e., a stock option that has an exercise price per share that is less than the per-share cash consideration of $16.73) (each, an "In-The-Money Company Stock Option"), whether vested or unvested, was canceled, with the holder becoming entitled to receive merger consideration based on each share of Net Option Stock that is associated with such In-The-Money Company Stock Option. The number of shares of "Net Option Stock" subject to an In-The-Money Company Stock Option is the number of shares of Company Common Stock equal to the excess of $16.73 over the per-share exercise price of such In-The-Money Company Stock Option multiplied by the number of shares of Company Common Stock underlying such In-The-Money Company Stock Option divided by $16.73.

F6: Pursuant to the Merger Agreement, as of the Effective Time, each outstanding share of Net Option Stock associated with vested In-The-Money Company Stock Options ("Vested Net Option Stock") was converted into the right to receive, at the election of the holder, and subject to proration in accordance with the Merger Agreement: (i) the Cash Consideration or (ii) the Stock Consideration.

F7: Pursuant to the Merger Agreement, as of the Effective Time, each outstanding share of Net Option Stock associated with unvested In-The-Money Company Stock Options ("Unvested Net Option Stock") was converted into the right to receive, at the election of the holder, and subject to proration in accordance with the Merger Agreement: (i) the Restricted Cash Consideration or (ii) the Restricted Stock Consideration, in either case, subject to substantially the same terms and conditions as were applicable under such In-The-Money Company Stock Options underlying the Unvested Net Option Stock.

F8: Pursuant to the Merger Agreement, as of the Effective Time, each outstanding out-of-the-money Company Stock option (i.e., a stock option that has an exercise price per share that is greater than the per-share cash consideration of $16.73), whether vested or unvested, was canceled for no consideration.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
June 05, 2025 Filed Jun 9, 2025 21:41 UTC Definitive Healthcare Corp. DH · Entity 1538 GrantClass A Common Stock 55,911 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-016333 · form4-06092025_090658.xml · nonDerivative · entry 1

Larsen Jill · CIK 0001738092 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 114,751

F1 · shares: Represents restricted stock units ("RSUs"), each representing a contingent right to receive one share of the Issuer's Class A Common Stock, par value $0.001, vesting on the earlier of June 5, 2026 or the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date.

Read SEC document
October 31, 2024 Filed Nov 4, 2024 21:19 UTC Sterling Check Corp. STER · Entity 11356 Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative 73,101 Not disclosed Strike: $9.68 Not disclosed
Disclosure

SEC source: 0000895345-24-000522 · form4.xml · derivative · entry 5

Larsen Jill · CIK 0001738092 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 73,101 shares

Expires not disclosed

F5 · kind: Pursuant to the Merger Agreement, as of the Effective Time, each outstanding in-the-money Company stock option (i.e., a stock option that has an exercise price per share that is less than the per-share cash consideration of $16.73) (each, an "In-The-Money Company Stock Option"), whether vested or unvested, was canceled, with the holder becoming entitled to receive merger consideration based on each share of Net Option Stock that is associated with such In-The-Money Company Stock Option. The number of shares of "Net Option Stock" subject to an In-The-Money Company Stock Option is the number of shares of Company Common Stock equal to the excess of $16.73 over the per-share exercise price of such In-The-Money Company Stock Option multiplied by the number of shares of Company Common Stock underlying such In-The-Money Company Stock Option divided by $16.73.

F6 · kind: Pursuant to the Merger Agreement, as of the Effective Time, each outstanding share of Net Option Stock associated with vested In-The-Money Company Stock Options ("Vested Net Option Stock") was converted into the right to receive, at the election of the holder, and subject to proration in accordance with the Merger Agreement: (i) the Cash Consideration or (ii) the Stock Consideration.

F7 · kind: Pursuant to the Merger Agreement, as of the Effective Time, each outstanding share of Net Option Stock associated with unvested In-The-Money Company Stock Options ("Unvested Net Option Stock") was converted into the right to receive, at the election of the holder, and subject to proration in accordance with the Merger Agreement: (i) the Restricted Cash Consideration or (ii) the Restricted Stock Consideration, in either case, subject to substantially the same terms and conditions as were applicable under such In-The-Money Company Stock Options underlying the Unvested Net Option Stock.

F5 · price: Pursuant to the Merger Agreement, as of the Effective Time, each outstanding in-the-money Company stock option (i.e., a stock option that has an exercise price per share that is less than the per-share cash consideration of $16.73) (each, an "In-The-Money Company Stock Option"), whether vested or unvested, was canceled, with the holder becoming entitled to receive merger consideration based on each share of Net Option Stock that is associated with such In-The-Money Company Stock Option. The number of shares of "Net Option Stock" subject to an In-The-Money Company Stock Option is the number of shares of Company Common Stock equal to the excess of $16.73 over the per-share exercise price of such In-The-Money Company Stock Option multiplied by the number of shares of Company Common Stock underlying such In-The-Money Company Stock Option divided by $16.73.

F6 · price: Pursuant to the Merger Agreement, as of the Effective Time, each outstanding share of Net Option Stock associated with vested In-The-Money Company Stock Options ("Vested Net Option Stock") was converted into the right to receive, at the election of the holder, and subject to proration in accordance with the Merger Agreement: (i) the Cash Consideration or (ii) the Stock Consideration.

F7 · price: Pursuant to the Merger Agreement, as of the Effective Time, each outstanding share of Net Option Stock associated with unvested In-The-Money Company Stock Options ("Unvested Net Option Stock") was converted into the right to receive, at the election of the holder, and subject to proration in accordance with the Merger Agreement: (i) the Restricted Cash Consideration or (ii) the Restricted Stock Consideration, in either case, subject to substantially the same terms and conditions as were applicable under such In-The-Money Company Stock Options underlying the Unvested Net Option Stock.

F5 · derivative.exercise_date: Pursuant to the Merger Agreement, as of the Effective Time, each outstanding in-the-money Company stock option (i.e., a stock option that has an exercise price per share that is less than the per-share cash consideration of $16.73) (each, an "In-The-Money Company Stock Option"), whether vested or unvested, was canceled, with the holder becoming entitled to receive merger consideration based on each share of Net Option Stock that is associated with such In-The-Money Company Stock Option. The number of shares of "Net Option Stock" subject to an In-The-Money Company Stock Option is the number of shares of Company Common Stock equal to the excess of $16.73 over the per-share exercise price of such In-The-Money Company Stock Option multiplied by the number of shares of Company Common Stock underlying such In-The-Money Company Stock Option divided by $16.73.

F6 · derivative.exercise_date: Pursuant to the Merger Agreement, as of the Effective Time, each outstanding share of Net Option Stock associated with vested In-The-Money Company Stock Options ("Vested Net Option Stock") was converted into the right to receive, at the election of the holder, and subject to proration in accordance with the Merger Agreement: (i) the Cash Consideration or (ii) the Stock Consideration.

F7 · derivative.exercise_date: Pursuant to the Merger Agreement, as of the Effective Time, each outstanding share of Net Option Stock associated with unvested In-The-Money Company Stock Options ("Unvested Net Option Stock") was converted into the right to receive, at the election of the holder, and subject to proration in accordance with the Merger Agreement: (i) the Restricted Cash Consideration or (ii) the Restricted Stock Consideration, in either case, subject to substantially the same terms and conditions as were applicable under such In-The-Money Company Stock Options underlying the Unvested Net Option Stock.

F5 · derivative.expiration_date: Pursuant to the Merger Agreement, as of the Effective Time, each outstanding in-the-money Company stock option (i.e., a stock option that has an exercise price per share that is less than the per-share cash consideration of $16.73) (each, an "In-The-Money Company Stock Option"), whether vested or unvested, was canceled, with the holder becoming entitled to receive merger consideration based on each share of Net Option Stock that is associated with such In-The-Money Company Stock Option. The number of shares of "Net Option Stock" subject to an In-The-Money Company Stock Option is the number of shares of Company Common Stock equal to the excess of $16.73 over the per-share exercise price of such In-The-Money Company Stock Option multiplied by the number of shares of Company Common Stock underlying such In-The-Money Company Stock Option divided by $16.73.

F6 · derivative.expiration_date: Pursuant to the Merger Agreement, as of the Effective Time, each outstanding share of Net Option Stock associated with vested In-The-Money Company Stock Options ("Vested Net Option Stock") was converted into the right to receive, at the election of the holder, and subject to proration in accordance with the Merger Agreement: (i) the Cash Consideration or (ii) the Stock Consideration.

F7 · derivative.expiration_date: Pursuant to the Merger Agreement, as of the Effective Time, each outstanding share of Net Option Stock associated with unvested In-The-Money Company Stock Options ("Unvested Net Option Stock") was converted into the right to receive, at the election of the holder, and subject to proration in accordance with the Merger Agreement: (i) the Restricted Cash Consideration or (ii) the Restricted Stock Consideration, in either case, subject to substantially the same terms and conditions as were applicable under such In-The-Money Company Stock Options underlying the Unvested Net Option Stock.

Read SEC document
October 31, 2024 Filed Nov 4, 2024 21:19 UTC Sterling Check Corp. STER · Entity 11356 Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative 24,424 Not disclosed Strike: $23.00 Not disclosed
Disclosure

SEC source: 0000895345-24-000522 · form4.xml · derivative · entry 4

Larsen Jill · CIK 0001738092 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 24,424 shares

Expires not disclosed

F8 · kind: Pursuant to the Merger Agreement, as of the Effective Time, each outstanding out-of-the-money Company Stock option (i.e., a stock option that has an exercise price per share that is greater than the per-share cash consideration of $16.73), whether vested or unvested, was canceled for no consideration.

F8 · price: Pursuant to the Merger Agreement, as of the Effective Time, each outstanding out-of-the-money Company Stock option (i.e., a stock option that has an exercise price per share that is greater than the per-share cash consideration of $16.73), whether vested or unvested, was canceled for no consideration.

F8 · derivative.exercise_date: Pursuant to the Merger Agreement, as of the Effective Time, each outstanding out-of-the-money Company Stock option (i.e., a stock option that has an exercise price per share that is greater than the per-share cash consideration of $16.73), whether vested or unvested, was canceled for no consideration.

F8 · derivative.expiration_date: Pursuant to the Merger Agreement, as of the Effective Time, each outstanding out-of-the-money Company Stock option (i.e., a stock option that has an exercise price per share that is greater than the per-share cash consideration of $16.73), whether vested or unvested, was canceled for no consideration.

Read SEC document
October 31, 2024 Filed Nov 4, 2024 21:19 UTC Sterling Check Corp. STER · Entity 11356 Disposition to issuerCommon Stock 12,756 Not disclosed Not disclosed
Disclosure

SEC source: 0000895345-24-000522 · form4.xml · nonDerivative · entry 3

Larsen Jill · CIK 0001738092 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F3 · security: This number reflects the number of shares of Company Common Stock subject to outstanding restricted stock awards.

F4 · kind: Pursuant to the Merger Agreement, as of the Effective Time, each restricted share of Company Common Stock (each, a "Company Restricted Share") was converted into the right to receive, at the election of the holder of such Company Restricted Share, and subject to proration in accordance with the Merger Agreement: (i) $16.73 per share in restricted cash (the "Restricted Cash Consideration") or (ii) 0.979 shares of Stock Consideration, in the form of restricted stock of Parent (the "Restricted Stock Consideration"), in either case, subject to substantially the same terms and conditions as were applicable to such Company Restricted Shares.

F3 · shares: This number reflects the number of shares of Company Common Stock subject to outstanding restricted stock awards.

F4 · price: Pursuant to the Merger Agreement, as of the Effective Time, each restricted share of Company Common Stock (each, a "Company Restricted Share") was converted into the right to receive, at the election of the holder of such Company Restricted Share, and subject to proration in accordance with the Merger Agreement: (i) $16.73 per share in restricted cash (the "Restricted Cash Consideration") or (ii) 0.979 shares of Stock Consideration, in the form of restricted stock of Parent (the "Restricted Stock Consideration"), in either case, subject to substantially the same terms and conditions as were applicable to such Company Restricted Shares.

Read SEC document
October 31, 2024 Filed Nov 4, 2024 21:19 UTC Sterling Check Corp. STER · Entity 11356 Disposition to issuerCommon Stock 30,982 Not disclosed Not disclosed
Disclosure

SEC source: 0000895345-24-000522 · form4.xml · nonDerivative · entry 2

Larsen Jill · CIK 0001738092 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Owned through DigitalHR, LLC.

Disclosed balance after: 0

F1 · kind: The shares of Company common stock ("Company Common Stock") were disposed of pursuant to the Agreement and Plan of Merger, dated as of February 28, 2024 (the "Merger Agreement"), by and among Sterling Check Corp., a Delaware corporation (the "Company"), First Advantage Corporation, a Delaware corporation ("Parent"), and Starter Merger Sub, Inc., a Delaware corporation and an indirect wholly-owned subsidiary of Parent, whereby at the effective time of the merger contemplated therein (the "Effective Time"), [Footnote continued below]

F2 · kind: [Footnote continued from above] each share of Company Common Stock issued and outstanding immediately prior to the Effective Time was converted into the right to receive, at the election of the holder of such share of Company Common Stock, and subject to proration in accordance with the Merger Agreement: (i) $16.73 per share in cash, without interest (the "Cash Consideration") or (ii) 0.979 shares of common stock, par value $0.001 per share, of Parent, together with cash in lieu of fractional shares, if any, at the rate per share of common stock of Parent of the last reported sale price of common stock of Parent on NASDAQ (as reported in The Wall Street Journal or, if not reported therein, in another authoritative source mutually selected by Parent and the Company) on the last complete trading day prior to the date of the Effective Time (the "Stock Consideration").

F1 · price: The shares of Company common stock ("Company Common Stock") were disposed of pursuant to the Agreement and Plan of Merger, dated as of February 28, 2024 (the "Merger Agreement"), by and among Sterling Check Corp., a Delaware corporation (the "Company"), First Advantage Corporation, a Delaware corporation ("Parent"), and Starter Merger Sub, Inc., a Delaware corporation and an indirect wholly-owned subsidiary of Parent, whereby at the effective time of the merger contemplated therein (the "Effective Time"), [Footnote continued below]

F2 · price: [Footnote continued from above] each share of Company Common Stock issued and outstanding immediately prior to the Effective Time was converted into the right to receive, at the election of the holder of such share of Company Common Stock, and subject to proration in accordance with the Merger Agreement: (i) $16.73 per share in cash, without interest (the "Cash Consideration") or (ii) 0.979 shares of common stock, par value $0.001 per share, of Parent, together with cash in lieu of fractional shares, if any, at the rate per share of common stock of Parent of the last reported sale price of common stock of Parent on NASDAQ (as reported in The Wall Street Journal or, if not reported therein, in another authoritative source mutually selected by Parent and the Company) on the last complete trading day prior to the date of the Effective Time (the "Stock Consideration").

Read SEC document
October 31, 2024 Filed Nov 4, 2024 21:19 UTC Sterling Check Corp. STER · Entity 11356 Disposition to issuerCommon Stock 34,415 Not disclosed Not disclosed
Disclosure

SEC source: 0000895345-24-000522 · form4.xml · nonDerivative · entry 1

Larsen Jill · CIK 0001738092 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The shares of Company common stock ("Company Common Stock") were disposed of pursuant to the Agreement and Plan of Merger, dated as of February 28, 2024 (the "Merger Agreement"), by and among Sterling Check Corp., a Delaware corporation (the "Company"), First Advantage Corporation, a Delaware corporation ("Parent"), and Starter Merger Sub, Inc., a Delaware corporation and an indirect wholly-owned subsidiary of Parent, whereby at the effective time of the merger contemplated therein (the "Effective Time"), [Footnote continued below]

F2 · kind: [Footnote continued from above] each share of Company Common Stock issued and outstanding immediately prior to the Effective Time was converted into the right to receive, at the election of the holder of such share of Company Common Stock, and subject to proration in accordance with the Merger Agreement: (i) $16.73 per share in cash, without interest (the "Cash Consideration") or (ii) 0.979 shares of common stock, par value $0.001 per share, of Parent, together with cash in lieu of fractional shares, if any, at the rate per share of common stock of Parent of the last reported sale price of common stock of Parent on NASDAQ (as reported in The Wall Street Journal or, if not reported therein, in another authoritative source mutually selected by Parent and the Company) on the last complete trading day prior to the date of the Effective Time (the "Stock Consideration").

F1 · price: The shares of Company common stock ("Company Common Stock") were disposed of pursuant to the Agreement and Plan of Merger, dated as of February 28, 2024 (the "Merger Agreement"), by and among Sterling Check Corp., a Delaware corporation (the "Company"), First Advantage Corporation, a Delaware corporation ("Parent"), and Starter Merger Sub, Inc., a Delaware corporation and an indirect wholly-owned subsidiary of Parent, whereby at the effective time of the merger contemplated therein (the "Effective Time"), [Footnote continued below]

F2 · price: [Footnote continued from above] each share of Company Common Stock issued and outstanding immediately prior to the Effective Time was converted into the right to receive, at the election of the holder of such share of Company Common Stock, and subject to proration in accordance with the Merger Agreement: (i) $16.73 per share in cash, without interest (the "Cash Consideration") or (ii) 0.979 shares of common stock, par value $0.001 per share, of Parent, together with cash in lieu of fractional shares, if any, at the rate per share of common stock of Parent of the last reported sale price of common stock of Parent on NASDAQ (as reported in The Wall Street Journal or, if not reported therein, in another authoritative source mutually selected by Parent and the Company) on the last complete trading day prior to the date of the Effective Time (the "Stock Consideration").

Read SEC document
May 22, 2024 Filed May 24, 2024 20:31 UTC Definitive Healthcare Corp. DH · Entity 1538 GrantClass A Common Stock 26,759 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-014517 · form4-05242024_040530.xml · nonDerivative · entry 1

Larsen Jill · CIK 0001738092 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,840

F1 · shares: Represents restricted stock units ("RSUs"), each representing a contingent right to receive one share of the Issuer's Class A Common Stock, par value $0.001, vesting on the earlier of May 22, 2025 or the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date.

Read SEC document
May 22, 2024 Filed May 24, 2024 16:10 UTC Sterling Check Corp. STER · Entity 11356 GrantCommon Stock 12,756 $0.00 $0.00
Disclosure

SEC source: 0001645070-24-000094 · wk-form4_1716581417.xml · nonDerivative · entry 1

Larsen Jill · CIK 0001738092 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,171

F1 · shares: Annual award grant of restricted stock to independent non-employee directors.

Read SEC document
June 01, 2023 Filed Jun 5, 2023 16:13 UTC Sterling Check Corp. STER · Entity 11356 GrantCommon Stock 14,225 $0.00 $0.00
Disclosure

SEC source: 0001645070-23-000049 · wk-form4_1685995992.xml · nonDerivative · entry 1

Larsen Jill · CIK 0001738092 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,415

F1 · shares: Annual award grant of restricted stock to independent non-employee directors.

Read SEC document
June 01, 2023 Filed Jun 8, 2023 22:02 UTC Definitive Healthcare Corp. DH · Entity 1538 GrantClass A Common Stock 17,536 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-035556 · doc4.xml · nonDerivative · entry 1

Larsen Jill · CIK 0001738092 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,081

F1 · shares: Represents restricted stock units ("RSUs"), each representing a contingent right to receive one share of the Issuer's Class A Common Stock, par value $0.001, vesting on the earlier of June 1, 2024 or the date of the Issuer's next annual meeting of stockholders, subject to Reporting the Person's continued service through the applicable vesting date.

Read SEC document
June 15, 2022 Filed Jun 16, 2022 16:06 UTC Sterling Check Corp. STER · Entity 11356 GrantCommon Stock 12,446 $0.00 $0.00
Disclosure

SEC source: 0001628280-22-017352 · wf-form4_165540993339804.xml · nonDerivative · entry 1

Larsen Jill · CIK 0001738092 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,190

F1 · shares: Annual award grant of restricted stock to independent non-employee directors.

Read SEC document
May 24, 2022 Filed May 26, 2022 20:18 UTC Definitive Healthcare Corp. DH · Entity 1538 GrantClass A Common Stock 14,545 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-22-019694 · doc4.xml · nonDerivative · entry 1

Larsen Jill · CIK 0001738092 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,545

F1 · shares: Represents shares of the Issuer's Class A Common Stock, par value $0.001 (the "Class A Common Stock") issuable pursuant to restricted stock units ("RSUs") as follows: (i) 4,475 immediately vested RSUs issued in respect of the Reporting Person's pro-rated service as a director since the Issuer's IPO, and (ii) 10,070 RSUs which vest upon the earlier of May 24, 2023 or the Issuer's next annual shareholder meeting, subject to the Reporting Person's continued service with the Issuer through the vesting date and subject to earlier forfeiture or acceleration.

F1 · price: Represents shares of the Issuer's Class A Common Stock, par value $0.001 (the "Class A Common Stock") issuable pursuant to restricted stock units ("RSUs") as follows: (i) 4,475 immediately vested RSUs issued in respect of the Reporting Person's pro-rated service as a director since the Issuer's IPO, and (ii) 10,070 RSUs which vest upon the earlier of May 24, 2023 or the Issuer's next annual shareholder meeting, subject to the Reporting Person's continued service with the Issuer through the vesting date and subject to earlier forfeiture or acceleration.

F1 · balance_after: Represents shares of the Issuer's Class A Common Stock, par value $0.001 (the "Class A Common Stock") issuable pursuant to restricted stock units ("RSUs") as follows: (i) 4,475 immediately vested RSUs issued in respect of the Reporting Person's pro-rated service as a director since the Issuer's IPO, and (ii) 10,070 RSUs which vest upon the earlier of May 24, 2023 or the Issuer's next annual shareholder meeting, subject to the Reporting Person's continued service with the Issuer through the vesting date and subject to earlier forfeiture or acceleration.

Read SEC document
September 22, 2021 Filed Sep 24, 2021 16:43 UTC Sterling Check Corp. STER · Entity 11356 GrantStock Option (Right to Buy) · Derivative 24,424 $0.00 Strike: $23.00 $0.00
Disclosure

SEC source: 0000895345-21-000870 · form4.xml · derivative · entry 1

Larsen Jill · CIK 0001738092 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,424

Underlying: Common Stock · 24,424 shares

Expires 2031-09-22

F1 · derivative.exercise_date: This option is scheduled to vest with respect to one-third of the underlying shares on each of the first three anniversaries of September 22, 2021, subject to the reporting person's continued service with the issuer as of the applicable vesting date.

Read SEC document
October 28, 2019 Filed Oct 28, 2019 16:38 UTC Medidata Solutions, Inc. MDSO · Entity 154211 Disposition to issuerRestricted Stock Units (Performance Related) · Derivative 19,954 Not disclosed Strike: $0.00 Not disclosed
Disclosure

SEC source: 0001453814-19-000151 · wf-form4_157229502547702.xml · derivative · entry 4

Larsen Jill · CIK 0001738092 · EVP, Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 19,954 shares

Expires not disclosed

F6 · shares: Pursuant to the separation agreement by and between the reporting person and the Issuer, dated October 25, 2019, each of the reporting person's performance-based restricted stock units will be deemed a Non-Employee PSU under the terms of the Merger Agreement and will be cancelled and converted into the right to receive an amount in cash equal to the product of (1) the total number of shares of Issuer Common Stock then covered by such PSU based on the attainment of the applicable performance metrics as determined by the issuer's Compensation committee multiplied by (2) $92.25 per share.

F6 · price: Pursuant to the separation agreement by and between the reporting person and the Issuer, dated October 25, 2019, each of the reporting person's performance-based restricted stock units will be deemed a Non-Employee PSU under the terms of the Merger Agreement and will be cancelled and converted into the right to receive an amount in cash equal to the product of (1) the total number of shares of Issuer Common Stock then covered by such PSU based on the attainment of the applicable performance metrics as determined by the issuer's Compensation committee multiplied by (2) $92.25 per share.

F8 · derivative.exercise_date: Award of PBRSUs granted under the 2017 LTIP on February 12, 2019. The number of PBRSUs represented a target amount. Each PBRSU represented a contingent right to receive 0-225% of that target number of shares of the issuer's common stock, (i) 50% based on the issuer's TSR as compared to the TSR of companies in the Russell 2000 Index for the three years ending December 31, 2021, and (ii) 50% based on the Company's revenue attainment for the three years ending December 31, 2021. The shares would have vested immediately upon being earned.

F8 · derivative.expiration_date: Award of PBRSUs granted under the 2017 LTIP on February 12, 2019. The number of PBRSUs represented a target amount. Each PBRSU represented a contingent right to receive 0-225% of that target number of shares of the issuer's common stock, (i) 50% based on the issuer's TSR as compared to the TSR of companies in the Russell 2000 Index for the three years ending December 31, 2021, and (ii) 50% based on the Company's revenue attainment for the three years ending December 31, 2021. The shares would have vested immediately upon being earned.

Read SEC document
October 28, 2019 Filed Oct 28, 2019 16:38 UTC Medidata Solutions, Inc. MDSO · Entity 154211 Disposition to issuerRestricted Stock Units (Performance-Related) · Derivative 10,343 Not disclosed Strike: $0.00 Not disclosed
Disclosure

SEC source: 0001453814-19-000151 · wf-form4_157229502547702.xml · derivative · entry 3

Larsen Jill · CIK 0001738092 · EVP, Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,343 shares

Expires not disclosed

F6 · shares: Pursuant to the separation agreement by and between the reporting person and the Issuer, dated October 25, 2019, each of the reporting person's performance-based restricted stock units will be deemed a Non-Employee PSU under the terms of the Merger Agreement and will be cancelled and converted into the right to receive an amount in cash equal to the product of (1) the total number of shares of Issuer Common Stock then covered by such PSU based on the attainment of the applicable performance metrics as determined by the issuer's Compensation committee multiplied by (2) $92.25 per share.

F6 · price: Pursuant to the separation agreement by and between the reporting person and the Issuer, dated October 25, 2019, each of the reporting person's performance-based restricted stock units will be deemed a Non-Employee PSU under the terms of the Merger Agreement and will be cancelled and converted into the right to receive an amount in cash equal to the product of (1) the total number of shares of Issuer Common Stock then covered by such PSU based on the attainment of the applicable performance metrics as determined by the issuer's Compensation committee multiplied by (2) $92.25 per share.

F7 · derivative.exercise_date: Award of PBRSUs granted under the 2017 LTIP on April 23, 2018. The number of PBRSUs represented a target amount. Each PBRSU represented a contingent right to receive 0-200% of that target number of shares of the issuer's common stock, (i) 50% based on the issuer's TSR as compared to the TSR of companies in the Russell 2000 Index for the three years ending December 31, 2020, and (ii) 50% based on the Company's GAAP Net Income attainment for the three years ending December 31, 2020. The shares would have vested immediately upon being earned.

F7 · derivative.expiration_date: Award of PBRSUs granted under the 2017 LTIP on April 23, 2018. The number of PBRSUs represented a target amount. Each PBRSU represented a contingent right to receive 0-200% of that target number of shares of the issuer's common stock, (i) 50% based on the issuer's TSR as compared to the TSR of companies in the Russell 2000 Index for the three years ending December 31, 2020, and (ii) 50% based on the Company's GAAP Net Income attainment for the three years ending December 31, 2020. The shares would have vested immediately upon being earned.

Read SEC document
October 28, 2019 Filed Oct 28, 2019 16:38 UTC Medidata Solutions, Inc. MDSO · Entity 154211 Disposition to issuerStock Options (right to buy) · Derivative 17,200 Not disclosed Strike: $72.51 Not disclosed
Disclosure

SEC source: 0001453814-19-000151 · wf-form4_157229502547702.xml · derivative · entry 2

Larsen Jill · CIK 0001738092 · EVP, Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 17,200 shares

Expires 2028-04-23

F4 · shares: Pursuant to the Merger Agreement and by virtue of the Merger, each option to purchase Issuer Common Stock will be cancelled and converted into the right to receive an amount in cash (without interest and subject to deduction for any required withholding tax) equal to the product of (1) the total number of shares of Issuer Common Stock then covered by such option multiplied by (2) the excess, if any, of $92.25 per share over the exercise price per share under such option.

F4 · price: Pursuant to the Merger Agreement and by virtue of the Merger, each option to purchase Issuer Common Stock will be cancelled and converted into the right to receive an amount in cash (without interest and subject to deduction for any required withholding tax) equal to the product of (1) the total number of shares of Issuer Common Stock then covered by such option multiplied by (2) the excess, if any, of $92.25 per share over the exercise price per share under such option.

F5 · derivative.exercise_date: The options vested as to 25% of the shares on April 23, 2019 and 1/36th of the remaining options will become exercisable each month thereafter for the next 36 months.

F4 · derivative.underlying_shares: Pursuant to the Merger Agreement and by virtue of the Merger, each option to purchase Issuer Common Stock will be cancelled and converted into the right to receive an amount in cash (without interest and subject to deduction for any required withholding tax) equal to the product of (1) the total number of shares of Issuer Common Stock then covered by such option multiplied by (2) the excess, if any, of $92.25 per share over the exercise price per share under such option.

Read SEC document
October 28, 2019 Filed Oct 28, 2019 16:38 UTC Medidata Solutions, Inc. MDSO · Entity 154211 Disposition to issuerCommon Stock 45,555 $92.25 $4,202,448.75
Disclosure

SEC source: 0001453814-19-000151 · wf-form4_157229502547702.xml · nonDerivative · entry 1

Larsen Jill · CIK 0001738092 · EVP, Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · date: On October 28, 2019, pursuant to the Agreement and Plan of Merger, dated as of June 11, 2019, by and among Dassault Systemes SE ("DS"), Dassault Systemes Americas Corp., a Delaware corporation ("Parent"), 3DS Acquisition 6 Corp., a Delaware corporation and a wholly-owned subsidiary of Parent ("Merger Sub"), and Medidata Solutions, Inc., a Delaware corporation (the "Issuer"), Merger Sub merged with and into the Issuer, with the Issuer surviving as a wholly-owned subsidiary of Parent and an indirect wholly-owned subsidiary of DS (the "Merger"). Pursuant to the separation agreement by and between the reporting person and the Issuer, dated October 25, 2019, each of the reporting person's shares of restricted stock will be deemed a Non-Employee RSA under the terms of the Merger Agreement.

F2 · shares: Disposed of pursuant to the Merger Agreement and by virtue of the Merger, in which each share of Medidata common stock, par value $0.01 per share ("Issuer Common Stock"), issued and outstanding immediately prior to the completion of the Merger (other than restricted share awards held by continuing employees) was converted into the right to receive $92.25 in cash and without interest (the "Merger Consideration"). Such number of shares includes shares issued to the reporting person upon accelerated vesting of the reporting person's RSAs and Issuer PBRSUs (referred to below) immediately prior to the effective time of the Merger.

F3 · shares: Included are 174 shares which were purchased pursuant to the terms of the Medidata Solutions, Inc. Employee Stock Purchase Plan on June 30, 2019.

F2 · price: Disposed of pursuant to the Merger Agreement and by virtue of the Merger, in which each share of Medidata common stock, par value $0.01 per share ("Issuer Common Stock"), issued and outstanding immediately prior to the completion of the Merger (other than restricted share awards held by continuing employees) was converted into the right to receive $92.25 in cash and without interest (the "Merger Consideration"). Such number of shares includes shares issued to the reporting person upon accelerated vesting of the reporting person's RSAs and Issuer PBRSUs (referred to below) immediately prior to the effective time of the Merger.

Read SEC document
April 23, 2019 Filed Apr 24, 2019 16:58 UTC Medidata Solutions, Inc. MDSO · Entity 154211 Tax withholdingCommon Stock 2,343 $87.69 $205,457.67
Disclosure

SEC source: 0001453814-19-000071 · wf-form4_155613947865002.xml · nonDerivative · entry 1

Larsen Jill · CIK 0001738092 · EVP, Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,381

F1 · shares: Shares withheld by Medidata to satisfy the tax withholding obligation in connection with the vesting of previously awarded restricted stock.

Read SEC document
February 12, 2019 Filed Feb 14, 2019 16:55 UTC Medidata Solutions, Inc. MDSO · Entity 154211 GrantRestricted Stock Units (Performance Related) · Derivative 19,954 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001453814-19-000012 · wf-form4_155018132573786.xml · derivative · entry 2

Larsen Jill · CIK 0001738092 · EVP, Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,954

Underlying: Common Stock · Not disclosed shares

Expires not disclosed

F3 · derivative.exercise_date: Award of PBRSUs under the 2017 LTIP on February 12, 2019. The number of PBRSUs represents a target amount. Each PBRSU represents a contingent right to receive 0-225% of that target number of shares of the issuer's common stock, (i) 50% based on the issuer's TSR as compared to the TSR of companies in the Russell 2000 Index for the three years ending December 31, 2021, and (ii) 50% based on the Company's revenue attainment for the three years ending December 31, 2021. The shares will vest immediately upon being earned.

F3 · derivative.expiration_date: Award of PBRSUs under the 2017 LTIP on February 12, 2019. The number of PBRSUs represents a target amount. Each PBRSU represents a contingent right to receive 0-225% of that target number of shares of the issuer's common stock, (i) 50% based on the issuer's TSR as compared to the TSR of companies in the Russell 2000 Index for the three years ending December 31, 2021, and (ii) 50% based on the Company's revenue attainment for the three years ending December 31, 2021. The shares will vest immediately upon being earned.

F3 · derivative.underlying_shares: Award of PBRSUs under the 2017 LTIP on February 12, 2019. The number of PBRSUs represents a target amount. Each PBRSU represents a contingent right to receive 0-225% of that target number of shares of the issuer's common stock, (i) 50% based on the issuer's TSR as compared to the TSR of companies in the Russell 2000 Index for the three years ending December 31, 2021, and (ii) 50% based on the Company's revenue attainment for the three years ending December 31, 2021. The shares will vest immediately upon being earned.

Read SEC document
February 12, 2019 Filed Feb 14, 2019 16:55 UTC Medidata Solutions, Inc. MDSO · Entity 154211 GrantCommon Stock 19,954 $0.00 $0.00
Disclosure

SEC source: 0001453814-19-000012 · wf-form4_155018132573786.xml · nonDerivative · entry 1

Larsen Jill · CIK 0001738092 · EVP, Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,724

F1 · shares: Award of shares of restricted stock under the issuer's 2017 Long-Term Incentive Plan (the "2017 LTIP") on February 12, 2019. The restrictions will lapse with respect to one-fourth of the shares on each of February 12, 2020, February 12, 2021, February 12, 2022, and February 12, 2023.

F2 · balance_after: Included are 174 shares which were purchased pursuant to the terms of the Medidata Solutions, Inc. Employee Stock Purchase Plan on December 31, 2018.

Read SEC document
April 23, 2018 Filed Apr 25, 2018 16:12 UTC Medidata Solutions, Inc. MDSO · Entity 154211 GrantStock Options (right to buy) · Derivative 17,200 $0.00 Strike: $72.51 $0.00
Disclosure

SEC source: 0001453814-18-000067 · wf-form4_152468710529724.xml · derivative · entry 3

Larsen Jill · CIK 0001738092 · EVP, Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,200

Underlying: Common Stock · 17,200 shares

Expires 2028-04-23

F4 · price: Granted as compensation for services.

F3 · derivative.exercise_date: The options vested as to 25% of the shares on April 23, 2019 and 1/36th of the remaining options will become exercisable each month thereafter for the next 36 months.

Read SEC document
April 23, 2018 Filed Apr 25, 2018 16:12 UTC Medidata Solutions, Inc. MDSO · Entity 154211 GrantRestricted Stock Units (Performance-Related) · Derivative 10,343 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001453814-18-000067 · wf-form4_152468710529724.xml · derivative · entry 2

Larsen Jill · CIK 0001738092 · EVP, Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,343

Underlying: Common Stock · Not disclosed shares

Expires not disclosed

F2 · derivative.exercise_date: Award of PBRSUs under the 2017 LTIP on April 23, 2018. The number of PBRSUs represents a target amount. Each PBRSU represents a contingent right to receive 0-200% of that target number of shares of the issuer's common stock, (i) 50% based on the issuer's TSR as compared to the TSR of companies in the Russell 2000 Index for the three years ending December 31, 2020, and (ii) 50% based on the Company's GAAP Net Income attainment for the three years ending December 31, 2020. The shares will vest immediately upon being earned.

F2 · derivative.expiration_date: Award of PBRSUs under the 2017 LTIP on April 23, 2018. The number of PBRSUs represents a target amount. Each PBRSU represents a contingent right to receive 0-200% of that target number of shares of the issuer's common stock, (i) 50% based on the issuer's TSR as compared to the TSR of companies in the Russell 2000 Index for the three years ending December 31, 2020, and (ii) 50% based on the Company's GAAP Net Income attainment for the three years ending December 31, 2020. The shares will vest immediately upon being earned.

F2 · derivative.underlying_shares: Award of PBRSUs under the 2017 LTIP on April 23, 2018. The number of PBRSUs represents a target amount. Each PBRSU represents a contingent right to receive 0-200% of that target number of shares of the issuer's common stock, (i) 50% based on the issuer's TSR as compared to the TSR of companies in the Russell 2000 Index for the three years ending December 31, 2020, and (ii) 50% based on the Company's GAAP Net Income attainment for the three years ending December 31, 2020. The shares will vest immediately upon being earned.

Read SEC document
April 23, 2018 Filed Apr 25, 2018 16:12 UTC Medidata Solutions, Inc. MDSO · Entity 154211 GrantCommon Stock 27,582 $0.00 $0.00
Disclosure

SEC source: 0001453814-18-000067 · wf-form4_152468710529724.xml · nonDerivative · entry 1

Larsen Jill · CIK 0001738092 · EVP, Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,596

F1 · shares: Award of shares of restricted stock under the issuer's 2017 Long-Term Incentive Plan (the "2017 LTIP"). The restrictions will lapse with respect to one-fourth of the shares on each of April 23, 2019, April 23, 2020, April 23, 2021, and April 23, 2022.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.